Dec 19, 2025 09:06AM
Nov 16, 2025 03:00PM
Sep 11, 2025 08:18AM
Jul 29, 2025 06:30AM
Jul 29, 2025 06:30AM
Apr 12, 2025 04:00AM
Jan 6, 2025 10:35AM TD Cowen: '10 Potential "Thome Run" Catalysts to Watch in 2025'
Dec 21, 2024 10:00AM
May 9, 2024 04:01PM
Feb 29, 2024 04:01PM
May 9, 2023 04:01PM
Jan 9, 2023 08:13AM
Jan 9, 2023 08:00AM
Jan 9, 2023 08:00AM Xenon Pharmaceuticals Outlines Key Milestone Opportunities for 2023
Nov 8, 2022 04:01PM
Nov 8, 2022 04:01PM
Nov 3, 2022 08:30AM
Nov 3, 2022 08:30AM
Aug 9, 2022 04:01PM
Aug 9, 2022 04:01PM
Jun 21, 2022 07:01AM Xenon Pharmaceuticals (XENE) Announces Positive End-of-Phase 2 Meeting with the FDA
Jun 21, 2022 07:00AM
Jun 21, 2022 07:00AM
May 10, 2022 04:01PM
May 10, 2022 04:01PM
Apr 12, 2022 06:37AM
Mar 1, 2022 04:01PM
Mar 1, 2022 04:01PM Xenon Pharmaceuticals Reports 2021 Financial Results and Provides Corporate Update
Jan 19, 2022 06:04PM
Jan 12, 2022 08:04AM
Jan 12, 2022 08:01AM
Jan 12, 2022 08:00AM
Jan 12, 2022 08:00AM
Jan 10, 2022 08:34AM
Jan 10, 2022 08:30AM Xenon Pharmaceuticals Outlines Key Milestone Opportunities for 2022
Jan 10, 2022 08:30AM
Dec 3, 2021 07:01AM
Dec 3, 2021 07:00AM
Dec 3, 2021 07:00AM
Nov 10, 2021 04:01PM
Nov 10, 2021 04:01PM
Oct 4, 2021 07:01AM Xenon Pharmaceuticals (XENE) Phase 2b 'X-TOLE' Clinical Trial of XEN1101 for the Treatment of Focal Epilepsy Met its Primary Efficacy Endpoint
Oct 4, 2021 07:00AM
Oct 4, 2021 07:00AM
Sep 8, 2021 08:32AM
Sep 8, 2021 08:30AM
Sep 8, 2021 08:30AM
Aug 11, 2021 04:01PM
Aug 11, 2021 04:01PM Xenon Pharmaceuticals Reports Second Quarter 2021 Financial Results and Provides Corporate Update
May 11, 2021 04:01PM

312,667 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All